Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Microbiology
1 other identifier
observational
600
1 country
2
Brief Summary
- Review key history and clinical examination findings of cases with CLABSI.
- Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI.
- Determine antibiotic biogram of each organism isolated
- Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2024
CompletedFirst Posted
Study publicly available on registry
June 13, 2024
CompletedStudy Start
First participant enrolled
June 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedJune 13, 2024
June 1, 2024
3 months
June 9, 2024
June 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
• Microbiological diagnosis and Culture sensitivity tests
• Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI.
6 months
Determine antibiotic biogram of each organism isolated
Determine antibiotic biogram of each organism isolated
6 months
Secondary Outcomes (1)
•Determine the prevalence of occurrence of Primary or secondary Blood stream infection
4 months
Study Arms (4)
No of Positive CLABSI
No of +ve CLABSI in different types of cases,
Primary Blood stream infection
Participant with blood stream infection not related to other other infection in the body
Secondary Blood stream infection
Blood stream infection occur as a complication to infection in other parts of the body
Blood Prevalence of types microorg.
% and Prevalence of different microorg causing Blood stream infection
Interventions
Central line as a predisposing factor for Blood stream infection
Eligibility Criteria
Venous blood samples from cases with suspected sepsis, or bacteremia will be incubated with a medium which encourages promotes bacterial growth.
You may qualify if:
- Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture.
- Both sex, and all age-groups.
You may not qualify if:
- Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours.
- Samples proved contaminated by microbial flora will be rejected.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Prof. Refat Sadeq
Port Said, 22223, Egypt
Faculty of Medicine Portsaid Uni
Port Said, Egypt
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2024
First Posted
June 13, 2024
Study Start
June 25, 2024
Primary Completion
September 30, 2024
Study Completion
May 31, 2025
Last Updated
June 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- after one year
Publication in Medical journals